Indications of use
Osteoporosis is a disease of the bones. The underlying mechanism is an imbalance between bone formation and bone resorption, which can lead to a high risk of fracture. Low intensity vibration (LIV) is a safe and effective non-drug intervention to correct this imbalance and treat osteoporosis. Treatment with Marodyne LiV […]
Marodyne LiV stands for low intensity vibration, the latest treatment that is medically approved for safe and effective treatment of osteoporosis, age-related muscle weakness (sarcopenia) and other disorders where muscle strength and nerve activity are compromised […]
Bone consists of various types of tissue with different consistencies. Long, tubular bones have an outside consisting of a strong, dense structure of tissue fibres known as cortical or compact bone. Inside the bone case is sponge-like trabecular bone with fine trabeculae, this is the area that […]
Marodyne LiV is a bio-mechanical vibration treatment system which provides a gentle, yet highly effective, stimulus for muscles and bones. Its action is designed to build up bone mineral density as well as strengthening the muscles and providing postural stability […]
Bone mass is built up from birth to around the age of 30; after that we begin to slowly loose bone mass and bone density. Finding therapies to increase peak bone mass in children is critical if they have a metabolic, genetic, physical disability, disease or other limitation that prevent […]
The veins in our legs have a crucial role to play in transporting the blood from our lower body back to the heart. The pumping capacity of our heart alone is not sufficient to ensure full circulation of our blood. In order to overcome gravity and push our blood back […]
Conditions that involve muscle weakness – such as osteoporosis, osteoarthritis, Parkinson’s disease and Multiple Sclerosis – result in people being less physically active. This leads to an increased risk of falling. The deconditioning of the musculoskeletal system is linked to falls, general functional decline, increased frailty and immobility. All of […]
BTT Health – Committed to Science
BTT Health GmbH is a research and development company, specializing in safe intervention for illness, disease and injury. BTT Health is the manufacturer of the ‘Marodyne LiV’ – Low-intensity vibration therapy platform as well as the ultrasound bone growth stimulator ‘bone4ce’.
Qualified Leadership Team
Headquartered in Inning am Ammersee close to famous Munich/Bavaria in Germany, BTT Health’s medical leadership team includes experts in the fields of biophysical stimulation, chronic disease and injury, and medical device research, development, and manufacturing.
Acknowledged Scientific Expertise
BTT Health is known in the U.S. and worldwide as a provider of a safe, low-intensity vibration that is backed and supported by a Scientific Advisory Board that includes leading experts in the fields of biomedical engineering, orthopedics, osteoporosis, diabetes, metabolic disorders, obesity, trauma and reconstruction, rehabilitative medicine and stem cell biology.
BTT Health’s executive and scientific leadership team has a proven track record to building a successful customer orientated relationship and developing and manufacturing novel medical devices for the professional and consumer.
BTT Health’s team of scientists, researchers, developers, and manufacturers of medical devices is led by Chief Scientific Officer Dr. Clinton Rubin Ph.D. Dr. Rubin, brings over 35 years of biomedical research, medical device design, and industry experience to ensure BTT Health’s product pipeline is based on the most current and accurate science findings. Currently, Rubin is also SUNY Distinguished Professor and Chair of the Department of Biomedical Engineering at the State University of New York at Stony Brook, and Director of the NYSTAR Center for Advanced Technology in Medical Biotechnology.
Read more in the new scientific report from June 10, 2020 in Nature Research Journal:
Low Intensity Vibrations Augment Mesenchymal Stem Cell Proliferation and Differentiation Capacity during in vitro Expansion
Bas, G., Loisate, S., Hudon, S.F. et al.
Have we sparked your interest? For further information please fill in the contact form below.
Get in Touch
Tel.: +49 (0) 8143 99 241 20 • Fax: +49 (0) 8143 99 241 29